Management of Helicobacter pylori infection in the pediatric age

Gonzalo Galicia Poblet1, Teresa Alarcón Cavero2, Natalia Alonso Pérez3

  • 1Servicio de Pediatría, Hospital Universitario de Guadalajara, Sociedad Española de Gastroenterología, Hepatología y Nutrición Pediátrica (SEGHNP), Guadalajara, Spain.

Anales De Pediatria
|October 13, 2021
PubMed

Insights

This study addresses the challenges in managing Helicobacter pylori infections in children. It provides unified guidelines for diagnosis and treatment, aiming to standardize care across primary and hospital settings.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases

Background:

  • Helicobacter pylori infection management in children presents clinical challenges.
  • Questions persist regarding symptoms, diagnostics, and treatment efficacy.
  • Establishing clear criteria for pediatric H. pylori studies remains controversial.

Purpose of the Study:

  • To unify criteria for H. pylori study indications in children and adolescents.
  • To standardize diagnosis and treatment recommendations for H. pylori infection.
  • To provide guidance applicable to both primary and hospital care settings.

Main Methods:

  • Review and synthesis of existing ESPGHAN/NASPGHAN guidelines (2011, 2017).
  • Consensus-building on diagnostic and therapeutic approaches.
  • Development of unified criteria for study initiation.

Main Results:

  • Established clear indications for H. pylori investigations in pediatric patients.
  • Provided updated recommendations for H. pylori diagnosis.
  • Outlined evidence-based treatment strategies for children and adolescents.

Conclusions:

  • The guidelines aim to resolve controversies in pediatric H. pylori management.
  • Standardized criteria and recommendations will improve clinical practice.
  • Unified guidance ensures consistent care for H. pylori infection in children.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
624
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
167
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
576
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
234
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
33
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
598